Search Result "GLP1"
Combination Therapies of DPP4 Inhibitors and GLP1 Analogues with Insulin in Type 2 Diabetic Patients: A Systematic Review
Journal: Current Vascular Pharmacology
Volume: 11 Issue: 6 Year: 2013 Page: 992-1000
Author(s): Evangelos C. Rizos,Evangelia E. Ntzani,Nikolaos Papanas,Vasilis Tsimihodimos,Zoi Mitrogianni,Efstratios Maltezos,Moses S. Elisaf
Glucagon-Like Peptide 1 and the Cardiovascular System
Journal: Current Diabetes Reviews
Volume: 10 Issue: 5 Year: 2014 Page: 302-310
Author(s): Stephen Fava
In Silico Pharmacogenomic Assessment of Glucagon-like Peptide-1 (GLP1)Agonists and the Genetic Addiction Risk Score (GARS) Related Pathways:Implications for Suicidal Ideation and Substance Use Disorder
Journal: Current Neuropharmacology
Volume: 23 Issue: 8 Year: 2025 Page: 974-995
Author(s): Mark S. Gold,John Wesson Ashford,Panayotis K. Thanos,Gene Jack Wang,Jean Lud Cadet,Eliot L. Gardner,Jag H. Khalsa,Eric R. Braverman,Catherine A. Dennen,Edward J. Modestino,Paul R. Carney,Rossano Kepler Alvim Fiorelli,Aryeh R. Pollack,Rajendra D. Badgaiyan
Evaluation of the Influence of the Conjugation Site of the Chelator Agent HYNIC to GLP1 Antagonist Radiotracer for Insulinoma Diagnosis
Journal: Current Radiopharmaceuticals
Volume: 10 Issue: 1 Year: 2017 Page: 65-72
Author(s): Bluma Linkowski Faintuch,Daniele Seo,Erica Aparecida de Oliveira,Roselaine Campos Targino,Ana Maria Moro
Redefining Cardiovascular (CV) Death as a Primary Endpoint Component in Cardiovascular Outcome Trials
Journal: Current Diabetes Reviews
Volume: 16 Issue: 9 Year: 2020 Page: 917-921
Author(s): Samit Ghosal,Binayak Sinha
Diabetes without Manifest Cardiovascular Disease: A Novel Approach in Risk Stratification and Treatment Selection
Journal: Current Diabetes Reviews
Volume: 16 Issue: 8 Year: 2020 Page: 869-873
Author(s): Emile Andari,Samir Arnaout,Sami T. Azar,Elie Chammas,Selim Jambart,Mounzer Saleh,Rita Nemr,Antoine Sarkis
Sodium Glucose Cotransporter-2 Inhibitor Treatment and the Risk of Diabetic Ketoacidosis in Denmark: A Retrospective Cohort Study of Five Years of Use
Journal: Current Drug Safety
Volume: 16 Issue: 1 Year: 2021 Page: 73-81
Author(s): Henrik V.B. Laursen,Johan B. Røikjer,Jakob Dal,Morten Hasselstrøm Jensen
Screening GLP-1 Receptor Ligands from Natural Products in Herbs through High-Content Technique
Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 22 Issue: 7 Year: 2019 Page: 445-454
Author(s): Kunhao Qin,Shengting Zhang,Jie Wang,Dongbo Liu,Yingying Xiang,Xiuling Ji,Yunlin Wei
Editorial: Can Glucagon Like Peptide 1 (GLP1) Agonists or Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors Ameliorate Non-Alcoholic Steatohepatitis in People with or without Diabetes?
Journal: Current Vascular Pharmacology
Volume: 14 Issue: 6 Year: 2016 Page: 494-497
Author(s): Vasilios G. Athyros, Niki Katsiki, Asterios Karagiannis
The Co-Existence of NASH and Chronic Kidney Disease Boosts Cardiovascular Risk: Are there any Common Therapeutic Options?
Journal: Current Vascular Pharmacology
Volume: 16 Issue: 3 Year: 2018 Page: 254-268
Author(s): Marianna Papademetriou,Vasilios G. Athyros,Eleni Geladari,Michael Doumas,Costas Tsioufis,Vasilios Papademetriou